Regarding the ALK dependency, ALK-dependent “on-target” tumors are driven by ALK signaling, while ALK “off-target” means that the driver mutation and the tumor cells are based on a different mechanism such as by-pass signaling pathways activation, drug efflux mechanisms, or histological transition (such as small cell transformation) [28,29]. The gene discussed is ALK; the disease is neoplasm.